361 Capital LLC purchased a new stake in LHC Group (NASDAQ:LHCG) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,302 shares of the health services provider’s stock, valued at approximately $2,149,000. 361 Capital LLC owned 0.17% of LHC Group at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in LHCG. BlackRock Inc. lifted its holdings in LHC Group by 43,223.7% in the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after acquiring an additional 1,964,950 shares during the period. Royal Bank of Canada lifted its holdings in LHC Group by 50,943.5% in the second quarter. Royal Bank of Canada now owns 165,381 shares of the health services provider’s stock valued at $11,229,000 after acquiring an additional 165,057 shares during the period. Castleark Management LLC acquired a new position in LHC Group in the second quarter valued at approximately $7,661,000. AJO LP acquired a new position in LHC Group in the second quarter valued at approximately $6,300,000. Finally, Robeco Institutional Asset Management B.V. acquired a new position in LHC Group in the third quarter valued at approximately $5,197,000. 87.29% of the stock is owned by institutional investors.
In related news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 14.80% of the company’s stock.
Shares of LHC Group (NASDAQ LHCG) traded down $0.28 during trading on Friday, reaching $67.65. The company had a trading volume of 381,155 shares, compared to its average volume of 141,066. LHC Group has a 12 month low of $41.66 and a 12 month high of $76.14. The stock has a market cap of $1,240.00, a PE ratio of 29.52, a price-to-earnings-growth ratio of 2.04 and a beta of 0.70. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.
LHC Group (NASDAQ:LHCG) last announced its earnings results on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The company had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same period last year, the business posted $0.54 EPS. LHC Group’s revenue for the quarter was up 18.2% on a year-over-year basis. equities research analysts anticipate that LHC Group will post 2.4 EPS for the current year.
Several brokerages have recently weighed in on LHCG. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $75.00 target price on shares of LHC Group in a research note on Friday, November 3rd. Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Craig Hallum reissued a “buy” rating and issued a $80.00 price objective (up from $67.00) on shares of LHC Group in a research note on Tuesday, November 7th. Jefferies Group LLC increased their price objective on LHC Group from $68.00 to $83.00 and gave the company a “buy” rating in a research note on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Royal Bank Of Canada increased their price objective on LHC Group from $70.00 to $81.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. LHC Group currently has an average rating of “Buy” and an average target price of $76.90.
LHC Group Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.